Antibody-Mediated Rejection (AMR) in Kidney Transplantation: The Role of Anti-Peroxisomal trans-2-enoyl-CoA Reductase (PECR) Auto-Antibody.

被引：0
|
作者：
Freitas, M. [1 ]
Rebellato, L. [2 ]
Pham, T. [1 ]
Terasaki, P. [1 ]
机构：
[1] Terasaki Fdn Lab, Los Angeles, CA USA
[2] E Carolina Univ, Brody Sch Med, Dept Pathol, Greenville, NC 27858 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：333 / 333
页数：1
相关论文
共 50 条
  • [1] Evolution of peroxisomal trans-2-enoyl-CoA reductase (PECR) as candidate gene for meat quality
    Piorkowska, K.
    Tyra, M.
    Ropka-Molik, K.
    Podbielska, A.
    LIVESTOCK SCIENCE, 2017, 201 : 85 - 91
  • [2] Late Antibody-Mediated Rejection (AMR) after Kidney Transplantation
    Martina, M.
    Oppenheimer, F.
    Revuelta, I.
    Campistol Planas, J.
    Sole, M.
    Cid, J.
    Diekmann, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 325 - 325
  • [3] Anti-Peroxisomal Trans 2-Enoyl CoA Reductase Antibodies as a Biomarker for the Development of Transplant Glomerulopathy.
    Dinavahi, R.
    George, A.
    Tretin, A.
    DiPaola, N.
    Mehrotra, A.
    Nadasdy, T.
    Paz-Artal, E.
    Salomon, D. R.
    Sachidanandam, R.
    Heeger, P. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 34 - 35
  • [4] The role of complement in antibody-mediated rejection in kidney transplantation
    Mark D. Stegall
    Marcio F. Chedid
    Lynn D. Cornell
    Nature Reviews Nephrology, 2012, 8 : 670 - 678
  • [5] The role of complement in antibody-mediated rejection in kidney transplantation
    Stegall, Mark D.
    Chedid, Marcio F.
    Cornell, Lynn D.
    NATURE REVIEWS NEPHROLOGY, 2012, 8 (11) : 670 - 678
  • [6] Antibody-Mediated Rejection (AMR) after Pancreas and Pancreas-Kidney Transplantation
    Rangel, Erika B.
    Malheiros, Denise M. A. C.
    Castro, Maria Cristina R.
    Antunes, Irina
    Torres, Margareth A.
    Crescentini, Fabio
    Genzini, Tercio
    Perosa, Marcelo
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 6 - 6
  • [7] Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation
    Rangel, Erika B.
    Malheiros, Denise M. A. C.
    Ribeiro de Castro, Maria Cristina
    Antunes, Irina
    Torres, Margareth A.
    Crescentini, Fabio
    Genzini, Tercio
    Perosa, Marcelo
    TRANSPLANT INTERNATIONAL, 2010, 23 (06) : 602 - 610
  • [8] Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?
    Irure, J.
    Lopez-Hoyos, M.
    Rodrigo, E.
    Gomez-Roman, J.
    Ruiz, J. C.
    Arias, M.
    San Segundo, D.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (09) : 2888 - 2890
  • [9] Alemtuzumab is not superior to basiliximab in preventing antibody-mediated rejection (AMR) of the kidney after simultaneous pancreas-kidney transplantation (SPKT)
    Pascual, J.
    Pirsch, J.
    Torrealba, J.
    Odorico, J.
    Djamali, A.
    Becker, Y.
    Leverson, G.
    Knechtle, S.
    Sollinger, H.
    Samanieo, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 202 - 202
  • [10] Alemtuzumab is not superior to basiliximab to prevent acute antibody-mediated rejection (AMR) after simultaneous pancreas-kidney transplantation
    Pirsch, John D.
    Pascual, Julio
    Sasmaniego, Milagros D.
    Torrealba, Jose R.
    Odorico, Jon S.
    Becker, Yolanda T.
    Fernandez, Luis A.
    Knechtle, Stuart J.
    Sollinger, Hans W.
    XENOTRANSPLANTATION, 2007, 14 (05) : 381 - 381
12345